|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02566 JIUYUAN GENE
Nominal 
() | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 135,765 | 22,559 | 67,529 |
| Net Cash from / (used in) Investing Activities | -- | (46,983) | (58,942) | (62,863) |
| Net Cash from / (used in) Financing Activities | -- | (67,350) | 12,892 | 41,228 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 21,432 | (23,491) | 45,894 |
| Cash & Cash Equivalents at beginning of period | -- | 71,540 | 94,829 | 49,051 |
| Effect of Foreign Exchange Rate Changes | -- | 206 | 202 | (116) |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 93,178 | 71,540 | 94,829 |
| Remarks: | Real time quote last updated: 25/11/2024 10:46 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 105,348,000 |
| %Change | 9.326% |
| EPS / (LPS) | RMB 0.530 |
| NBV Per Share (¥) | RMB -- |